Hospital Inpatient Drug Spending Up 23%, Driven By Price Increases
Executive Summary
Older drugs and high-volume drugs contributed substantially to the increases, study conducted on behalf of hospital trade groups finds.
You may also be interested in...
The Super Bowl of Mismanaging Congressional Investigations: Shkreli Vs. Valeant
Which is stupider: Smirking, pleading the Fifth and then calling a Congressional Committee “imbeciles” on Twitter? Or spending four hours apologizing for excessive price increases and then running two DTC commercials during the Super Bowl?
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.